HAL (France)
open access
The role of the RhoB-Ral interaction in EGFR-mutated lung cancer
Lung cancer is the leading cause of cancer mortality worldwide. Drug resistance in tumors is a major reason. Recently, our team showed that the Ras-related GTPase RhoB hinders the response to EGFR-TKI and contributes to the acquisition of resistance. Later, the team showed that RhoB interacts with i
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Thioredoxin reductase-1 facilitates cellular plasticity and stemness mediated by TGF-β1 in non-small cell lung cancer.#1159537
- Targeted Induction Therapy for Stage III Unresectable EGFR Mutant Positive NSCLC#842304
- Prospective Translational Study Investigating Molecular Predictors of Resistance and Response to Regorafenib Monotherapy#1163530
- Second-line Immunotherapy for ES-SCLC#852143
- A Exploratory Study of Nivolumab Monotherapy or in Combination With Nab-paclitaxel and Carboplatin in Early Stage NSCLC in China#890166
Record · ID 1266279
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive